We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Compandia Appoints Dr Dave Tapolcazy as new Non Executive Chairman

News   May 14, 2010

 
Compandia Appoints Dr Dave Tapolcazy as new Non Executive Chairman
 
 
 

RELATED ARTICLES

Where Do Falling Fears Come From in Parkinson's disease?

News

UCalgary scientists discover a way to measure fear of falling in Parkinson's patients.

READ MORE

Harnessing AI to Improve Drug Combination Design

News

Artificial intelligence is having a positive impact on drug development and personalized medicine. With the ability to efficiently analyze small datasets that focus on the specific disease of interest, small dataset-based AI platforms can rationally design optimal drug combinations that are effective and based on real experimental data and not mechanistic assumptions or predictive modeling.

READ MORE

Cobra Biologics, GE Healthcare and Centre for Process Innovation Collaborate to Advance Gene Therapy

News

Innovate UK funded project supports development of scalable, cost effective production of regenerative medicines.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE